Prelude Capital Management’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-124,788
| Closed | -$22.9M | – | 2356 |
|
|
2021
Q2 | $22.9M | Buy |
124,788
+78,136
| +167% | +$13.4M | 1.27% | 14 |
|
|
2021
Q1 | $7.13M | Buy |
46,652
+36,752
| +371% | +$5.69M | 0.5% | 70 |
|
|
2020
Q4 | $1.55M | Buy |
9,900
+5,222
| +112% | +$671K | 0.12% | 364 |
|
|
2020
Q3 | $535K | Sell |
4,678
-6,496
| -58% | -$701K | 0.07% | 429 |
|
|
2020
Q2 | $1.25M | Buy |
11,174
+10,848
| +3,328% | +$1.15M | 0.2% | 262 |
|
|
2020
Q1 | $29K | Sell |
326
-2,247
| -87% | -$221K | 0.01% | 895 |
|
|
2019
Q4 | $278K | Buy |
2,573
+1,864
| +263% | +$199K | 0.04% | 750 |
|
|
2019
Q3 | $69K | Sell |
709
-11,134
| -94% | -$1.26M | 0.01% | 1070 |
|
|
2019
Q2 | $1.55M | Buy |
+11,843
| New | +$1.53M | 0.15% | 246 |
|
|
2019
Q1 | – | Sell |
-124
| Closed | -$15.4K | – | 2466 |
|
|
2018
Q4 | $12K | Buy |
+124
| New | +$14.7K | ﹤0.01% | 1350 |
|
|
2018
Q3 | – | Sell |
-3,894
| Closed | -$483K | – | 2264 |
|
|
2018
Q2 | $483K | Buy |
+3,894
| New | +$455K | 0.04% | 543 |
|
|
2018
Q1 | – | Sell |
-7,683
| Closed | -$918K | – | 1864 |
|
|
2017
Q4 | $919K | Buy |
+7,683
| New | +$936K | 0.09% | 274 |
|
|
2017
Q3 | – | Sell |
-12,470
| Closed | -$1.52M | – | 2056 |
|
|
2017
Q2 | $1.52M | Buy |
12,470
+9,312
| +295% | +$1.08M | 0.16% | 147 |
|
|
2017
Q1 | $383K | Buy |
3,158
+2,755
| +684% | +$355K | 0.05% | 372 |
|
|
2016
Q4 | $49K | Buy |
+403
| New | +$49.3K | 0.01% | 1052 |
|
|
2016
Q2 | – | Sell |
-775
| Closed | -$108K | – | 1848 |
|
|
2016
Q1 | $108K | Sell |
775
-4,482
| -85% | -$658K | 0.02% | 744 |
|
|
2015
Q4 | $1M | Buy |
5,257
+636
| +14% | +$111K | 0.18% | 157 |
|
|
2015
Q3 | $723K | Buy |
4,621
+186
| +4% | +$33.9K | 0.12% | 224 |
|
|
2015
Q2 | $802K | Sell |
4,435
-901
| -17% | -$155K | 0.12% | 211 |
|
|
2015
Q1 | $925K | Buy |
5,336
+3,441
| +182% | +$623K | 0.13% | 194 |
|
|
2014
Q4 | $351K | Sell |
1,895
-200
| -10% | -$37.1K | 0.06% | 426 |
|
|
2014
Q3 | $347K | Buy |
2,095
+328
| +19% | +$53.9K | 0.05% | 509 |
|
|
2014
Q2 | $276K | Sell |
1,767
-3,381
| -66% | -$534K | 0.05% | 609 |
|
|
2014
Q1 | $783K | Buy |
5,148
+1,176
| +30% | +$187K | 0.13% | 252 |
|
|
2013
Q4 | $528K | Hold |
3,972
| – | – | 0.1% | 337 |
|
|
2013
Q3 | $461K | Sell |
3,972
-6,000
| -60% | -$658K | 0.11% | 317 |
|
|
2013
Q2 | $920K | Buy |
+9,972
| New | +$961K | 0.26% | 117 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM